deCODE genetics (Nasdaq:DCGN) today announced that its presentation
at the 25th Annual JP Morgan Healthcare Conference will be
webcast live. deCODE management will provide an update on
progress in its drug and diagnostic development programs.
The presentation will be delivered at 11:30am PST/2:30pm
EST/7:30pm GMT on Thursday, January 11, 2007 at the Westin
St. Francis Hotel in San Francisco. The webcast can be accessed
through the Investors
page on deCODE’s website, www.decode.com,
and those interested in listening should log on a few minutes
in advance in order to download any software or complete any
sign-in that may be required. The webcast will be archived
for at least one week.
About deCODE
deCODE
genetics
(Nasdaq:DCGN)
is a
global leader in applying human genetics to develop drugs
and diagnostics for common diseases.
Our population
approach
has enabled
us to discover and target key biological pathways involved
in conditions ranging from
heart
attack
to cancer.
We are turning these discoveries into new medicine to better
treat and prevent many of the
biggest
challenges
to public
health. deCODE is delivering on the promise of the new genetics.SM
Visit us on the web
at www.decode.com.
